Mkts

TELA Bio, Inc.

NASDAQ: TELA
$0.73-0.05 (-6.83%)
As of Nov 19, 4:00 PM ET

Key statistics

Day range
0.720.80
52-week range
0.501.50
Today
Open0.80
Previous close0.73
Volume164.7K
Valuation
Market cap32.99M
P/E ratio—
EPS (TTM)-0.77
Income & risk
Dividend / yield—
Beta1.44
Avg volume194.9K
Discussion

TELA News

Stories mentioning TELA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue19,05920,86920,68920,19718,52017,64918,95716,091
Cost of Goods Sold
Gross Profit12,52013,75513,96914,10512,51211,22112,85811,073
Operating Expenses
Research & Development2,3432,1292,3482,2032,5402,0292,0682,323
Sales General & Admin
Total Operating Expenses23,04620,40321,52323,18622,98419,57522,22322,643
Operating Income (Loss)(10,526)(6,648)(7,554)(9,081)(10,472)(8,354)(9,365)(11,570)
Interest Income
Interest Expense
Other Expense366.00277.00152.00379.00479.00285.00337.00301.00
Pretax Income(12,213)(8,896)(8,603)(9,890)(11,212)(9,352)(10,372)(12,600)
Tax Provision60.0033.0052.00
Net Income (Loss)(12,273)(9,041)(8,603)(9,923)(11,264)(9,208)(10,372)(12,600)
Earnings Per Share (Basic)(0.21)(0.19)(0.19)(0.22)(0.25)(0.32)(0.42)(0.51)
Earnings Per Share (Diluted)(0.21)(0.19)(0.19)(0.22)(0.25)(0.32)(0.42)(0.51)
Weighted Average Shares Outstanding (Basic)57,25746,94845,42245,36545,26728,52624,70424,663
Weighted Average Shares Outstanding (Diluted)57,25746,94845,42245,36545,26728,52624,70424,663

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TELA

TELA Bio, Inc. (NASDAQ: TELA) is a stock listed on the Nasdaq Stock Market under the ticker symbol TELA. It last traded at $0.7300 (Nov 19, 2026, 4:00 PM ET), down 6.8% on the day. That gives TELA Bio a market capitalisation of $33.0M.

Over the past 52 weeks TELA has traded between $0.5000 and $1.50.

Revenue for the quarter ended Mar 31, 2026 was $19.1M; a net loss of $12.3M. Revenue was up 2.9% from $18.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$19.1M-$12.3M-64.4%
Dec 31, 2025$20.9M-$9.0M-43.3%
Sep 30, 2025$20.7M-$8.6M-41.6%
Jun 30, 2025$20.2M-$9.9M-49.1%

From TELA Bio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…